Trieste, Italy

Andrés Muro

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Andrés Muro

Introduction

Andrés Muro is a notable inventor based in Trieste, Italy. He has made significant contributions to the field of genetic engineering, particularly in the treatment of hyperbilirubinemia. His work has implications for patients suffering from Crigler-Najjar syndrome, showcasing his commitment to advancing medical science.

Latest Patents

Muro holds a patent for a nucleic acid sequence that is useful in the treatment of hyperbilirubinemia. This invention specifically involves a codon-optimized UGT1A1 coding sequence, which has the potential to improve therapeutic outcomes for affected individuals.

Career Highlights

Throughout his career, Muro has worked with prominent organizations such as Genethon and the International Centre for Genetic Engineering and Biotechnology. His experience in these institutions has allowed him to develop and refine his innovative ideas in genetic treatments.

Collaborations

Muro has collaborated with esteemed colleagues in his field, including Federico Mingozzi and Giuseppe Ronzitti. These partnerships have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Andrés Muro's work exemplifies the intersection of innovation and medical science, particularly through his patent addressing hyperbilirubinemia. His contributions continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…